WS #7618
The Strait of Hormuz crisis continues to escalate, with multiple sources confirming the US may resume military operations against Iran within 24-48 hours. Trump's latest threat ('clock is ticking') is pushing oil prices higher, with WTI at $106.5 and Brent at $110.5. Bitcoin has slid below $77,000 as the Iran warning rattles risk assets, with crypto liquidations topping $672M amid a global bond selloff. The global bond rout continues with G7 10Y yields +15-20bp/week; UST 10Y ~4.6%, 30Y >5.1%. The IMF has upgraded UK growth forecast to 1% but warns the Iran war could hit the economy. Separately, Boston Scientific announced a $2B accelerated share buyback and invested $1.5B for a ~34% stake in MiRus. Brady Corp reported record adjusted EPS ($1.50 vs $1.34 estimate) and raised guidance. Regeneron shares are trading lower after Phase 3 trial failure for fianlimab. Hims & Hers announced a $300M convertible notes offering. The global bond selloff is a key theme at the G7 finance chief gathering.
Key developments
- US may resume war on Iran within 24-48 hours; Trump warns 'clock is ticking'
- Bitcoin slides below $77,000 as Trump's Iran warning rattles risk assets
- Global bond rout continues; G7 10Y yields +15-20bp/week
- Boston Scientific announces $2B accelerated share buyback and $1.5B MiRus stake
- Regeneron Phase 3 trial failure for fianlimab in melanoma
- Hims & Hers announces $300M convertible notes offering
- IMF upgrades UK growth forecast to 1% but warns of Iran war risks
- Brady Corp reports record Q3 EPS of $1.50, beats estimates, raises guidance